# Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

> **NCT05038098** · PHASE1 · NOT_YET_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 20 (estimated)

## Conditions studied

- Gastric Adenocarcinoma

## Interventions

- **PROCEDURE:** Gastrectomy
- **DRUG:** Indocyanine Green
- **OTHER:** Iron Conjugated Polymers in Saline Suspension

## Key facts

- **NCT ID:** NCT05038098
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2027-02-02
- **Final completion:** 2027-02-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05038098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05038098, "Magnetic Sentinel Lymph Node Mapping in Gastric Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05038098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
